Isaac Health
Category: AI in Healthcare
An AI-enabled brain health platform that provides a virtual-first clinical model for the screening, diagnosis, and management of dementia and other cognitive disorders. Isaac Health was founded in 2022. The company is led by Julius Bruch. Based in New York, USA. Team size: 11-50. Total funding raised: $16.2M. Latest round: Series A, $10.5M, 2025-08, led by N/A. Key investors include ["Meridian Street Capital","B Capital","Flare Capital Partners","Primetime Partners","Black Opal Ventures"].
- Founded
- 2022
- Headquarters
- New York, USA
- Team size
- 11-50
- Total funding
- $16.2M
Value proposition
Reduces specialist wait times from months to days while delivering validated clinical outcomes, including a 38% reduction in Emergency Department utilization and a 28% reduction in hospital stays.
Products and solutions
["Virtual Brain Health & Memory Clinic","AI-Powered Early Detection & Screening Tools","Smart Care Management Platform","Specialist-Led Behavioral & Mental Health Services","Dementia-Trained Care Navigator Program"]
Unique value
Combines proprietary AI screening with a behavioral neurology-led specialist model to provide 'Center of Excellence' level care in regions lacking local neurology infrastructure.
Target customer
Medicare Advantage and Medicaid health plans, risk-bearing health systems, Accountable Care Organizations (ACOs), and patients/caregivers in 'neurology deserts.'
Industries served
["Healthcare Technology (Healthtech)","Artificial Intelligence","Neurology & Geriatrics","Value-Based Care","Elder Care & Caregiver Support"]
Technology advantage
Leverages predictive machine learning to identify at-risk patients early and integrates directly into value-based care workflows to close Medicare Advantage coding gaps and reduce total cost of care.
How they differentiate
Isaac Health differentiates through a 'virtual-first' clinical model that combines proprietary AI-driven screening tools with specialist-led care, specifically optimized for value-based care (VBC) contracts and the CMS GUIDE model.
Main competitors
["Rippl Care","Synapticure","Linus Health"]
Key partnerships
["LillyDirect (Eli Lilly) for expanded dementia care access","Pearl Health for physician enablement in value-based care","CaringKind for community-based caregiver support","CMS (Centers for Medicare & Medicaid Services) GUIDE Model participant","Major national and regional Medicare Advantage plans"]
Notable customers
["Eli Lilly (LillyDirect)","Pearl Health","Medicare Advantage Plans","CaringKind"]
Major milestones
["Selected as a participant in the CMS GUIDE (Guiding an Improved Dementia Experience) Model","Partnered with Eli Lilly’s LillyDirect to expand access to specialized dementia care","Named to the 2025 New York Digital Health 100","Successfully scaled specialist-led dementia care services nationwide"]
Growth metrics
Achieved a 38% reduction in Emergency Department utilization and a 28% reduction in hospital stays for enrolled patients.
Market positioning
Specialized brain health and dementia care provider targeting the Medicare Advantage and Medicaid populations in 'neurology deserts.'
Geographic focus
United States (Nationwide, with a focus on regions lacking local neurology infrastructure)
Patents and IP
Holds patented AI screening capabilities for the detection and assessment of cognitive decline.
About Julius Bruch
Julius Bruch is a physician-scientist and former Associate Partner at McKinsey & Company, where he spent 7 years leading the healthcare practice's work in value-based care and digital health across the US, Europe, and Asia. He holds an MD and a PhD in Clinical Neurosciences from the University of Cambridge, specializing in neurodegenerative diseases.
Official website: https://isaac.health